Orphazyme A/S - ORPHA (CPH)

[Kavemeg (Karim Avena Meggaro)]

Orphazyme is a Danish biopharmaceutical company with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases.

Wiki page: Arimoclomol - Wikipedia

Google Finance link: https://www.google.co.uk/search?q=CPH:+ORPHA&stick=H4sIAAAAAAAAAONgecRowS3w8sc9YSn9SWtOXmPU5OIKzsgvd80rySypFJLmYoOyBKX4uXj10_UNDVPSKqqqKopSeADXckjHPQAAAA&tbm=fin#scso=_YuZHXfubOJTSxgPGx4f4DQ6:0